Comparable stake leader
BlackRock, Inc.
SEC ownership of Liquidia Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001819576.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
22 Jul 2026
- Public ticker
- LQDA on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
22 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001819576
- Issuer location
- Morrisville, NC
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Liquidia Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
22 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
12%
Farallon Capital Partners, L.P.
9.9%
FARALLON CAPITAL MANAGEMENT, L.L.C.
9.4%
Legend Aggregator, LP
2.2%
Paul B. Manning
0.76%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
12%
|
$841,291,460
10,551,901 shares
|
$0 | 30 Jun 2026 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
9.9%
|
$316,810,991
8,656,038 shares
|
+$3,308,640 | 31 Dec 2025 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. |
13D/G
13F
Company
|
9.4%
|
$662,594,660
8,365,038 shares
|
$0 | 30 Jun 2026 |
| Legend Aggregator, LP |
13D/G
|
2.2%
|
$26,101,005
1,860,371 shares
|
$0 | 31 Dec 2024 |
| Paul B. Manning |
3/4/5
Director
|
0.76%
|
$25,432,155
673,878 shares
|
-$31,739,534 | 16 Jun 2026 |
| Dr. Stephen M. Bloch |
3/4/5
Director
|
0.64%
|
$51,195,412
573,071 shares
|
-$118,662,602 | 22 Jul 2026 |
| Damian deGoa |
3/4/5
Director
|
0.1%
|
$3,485,402
92,353 shares
|
— | 16 Jun 2026 |
| Sanjeev Khindri |
3/4/5
Chief Development Officer
|
0.07%
|
$4,716,529
65,947 shares
|
-$355,352 | 13 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$230,369,886.
Buys
$635,788
Insiders: 2
Sells
$231,005,674
Insiders: 16
Net
-$230,369,886
Shares: -4,523,318
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 10,600
Shares: 4,533,918
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 10,600 | 2,386,354 | $635,788 | $159,648,841 | -$159,013,053 |
| 3-6 | 0 | 867,605 | $0 | $33,752,807 | -$33,752,807 |
| 6-9 | 0 | 252,476 | $0 | $9,173,395 | -$9,173,395 |
| 9-12 | 0 | 1,027,483 | $0 | $28,430,631 | -$28,430,631 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 20 reporting-owner rows connected to Liquidia Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
20
Largest Forms 3/4/5 holder
David Edward Johnson
Net 12M change
-$230,369,886
Latest report
27 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| David Edward Johnson | Director, 10%+ Owner | $388,997,597 | $0 | 0% | Mixed | 16 Jun 2026 |
| Caligan Partners LP | Director, Other*, 10%+ Owner | $388,851,827 | $0 | 0% | Mixed | 16 Jun 2026 |
| Roger Jeffs | Chief Executive Officer, Director | $166,601,648 | -$31,724,055 | -16% | Mixed | 10 Jul 2026 |
| Dr. Stephen M. Bloch | Director | $51,195,412 | -$118,662,602 | -70% | Mixed | 22 Jul 2026 |
| Russell Schundler | General Counsel | $45,847,288 | -$2,882,426 | -5.9% | Mixed | 10 Jul 2026 |
| Michael Kaseta | CFO and COO | $26,205,566 | -$16,528,066 | -39% | Mixed | 10 Jul 2026 |
| Paul B. Manning | Director | $25,432,155 | -$31,739,534 | -56% | Mixed | 16 Jun 2026 |
| Jason Adair | Chief Business Officer | $20,096,406 | -$3,421,887 | -15% | Mixed | 27 Jul 2026 |
| Dana Boyle | Chief Accounting Officer | $14,697,950 | -$2,331,571 | -14% | Filing P/S | 27 Jul 2026 |
| Scott Moomaw | Chief Commercial Officer | $13,988,610 | -$7,545,089 | -35% | Mixed | 10 Jul 2026 |
| Dr. Rajeev Saggar | Chief Medical Officer | $13,132,632 | -$5,747,831 | -30% | Mixed | 10 Jul 2026 |
| Sarah Krepp | Chief Human Resource Officer | $8,380,570 | -$3,674,435 | -30% | Filing P/S | 10 Jul 2026 |
| Sanjeev Khindri | Chief Development Officer | $4,716,529 | -$355,352 | -7% | Filing P/S | 13 Jul 2026 |
| Damian deGoa | Director | $3,485,402 | Mixed | 16 Jun 2026 | ||
| Arthur S. Kirsch | Director | $1,760,080 | -$1,731,300 | -50% | Mixed | 16 Jun 2026 |
| Raman Singh | Director | $1,684,600 | -$3,889,888 | -70% | Mixed | 16 Jun 2026 |
| Katherine Rielly-Gauvin | Director | $1,684,600 | Mixed | 16 Jun 2026 | ||
| Robert A. Lippe | Chief Operations Officer | $1,606,948 | Mixed | 30 Nov 2023 | ||
| Dr. Joanna Horobin | Director | $1,495,900 | -$135,850 | -8.3% | Mixed | 16 Jun 2026 |
| Dr. Tushar Shah | CMO and Head of R&D | $259,700 | Mixed | 16 Jan 2022 |
Recent insider transactions for Liquidia Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Dana Boyle | LQDA | Common Stock | Sale | -0.94% | $140,048 | $87.53 | -1,600 | 167,919 | 27 Jul 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Sale | -0.32% | $60,221 | $87.53 | -688 | 216,438 | 27 Jul 2026 | Direct |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -16.6% | $8,948,444 | $89.48 | -100,000 | 501,477 | 23 Jul 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -14.3% | $8,837,965 | $88.38 | -100,000 | 601,477 | 22 Jul 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -9.66% | $5,999,182 | $79.99 | -75,000 | 701,477 | 21 Jul 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -0.46% | $286,068 | $79.55 | -3,596 | 776,477 | 20 Jul 2026 | See footnote |
| Sarah Krepp | LQDA | Common Stock | Sale | -6.29% | $562,361 | $71.51 | -7,864 | 117,178 | 13 Jul 2026 | Direct |
| Sanjeev Khindri | LQDA | Common Stock | Sale | -1.77% | $84,740 | $71.51 | -1,185 | 65,947 | 13 Jul 2026 | Direct |
| Michael Kaseta | LQDA | Common Stock | Sale | -5.58% | $1,460,965 | $71.51 | -20,430 | 345,805 | 13 Jul 2026 | Direct |
| Roger Jeffs | LQDA | Common Stock | Sale | -3.02% | $2,520,683 | $71.51 | -35,249 | 1,130,426 | 13 Jul 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Sale | -3.49% | $562,289 | $71.51 | -7,863 | 217,126 | 13 Jul 2026 | Direct |
| Russell Schundler | LQDA | Common Stock | Sale | -2.37% | $1,053,926 | $71.51 | -14,738 | 605,962 | 13 Jul 2026 | Direct |
| Dr. Rajeev Saggar | LQDA | Common Stock | Sale | -5.46% | $709,816 | $71.51 | -9,926 | 171,799 | 13 Jul 2026 | Direct |
| Scott Moomaw | LQDA | Common Stock | Sale | -4.97% | $682,142 | $71.51 | -9,539 | 182,485 | 13 Jul 2026 | Direct |
| Dana Boyle | LQDA | Common Stock | Sale | -5.04% | $643,740 | $71.51 | -9,002 | 169,519 | 13 Jul 2026 | Direct |
| Sarah Krepp | LQDA | Common Stock | Options Exercise | 2.61% | 3,179 | 125,042 | 10 Jul 2026 | Direct | ||
| Sarah Krepp | LQDA | Performance Stock Units | Options Exercise | -9.09% | -3,179 | 31,787 | 10 Jul 2026 | Direct | ||
| Michael Kaseta | LQDA | Common Stock | Options Exercise | 3.64% | 12,879 | 366,235 | 10 Jul 2026 | Direct | ||
| Michael Kaseta | LQDA | Performance Stock Units | Options Exercise | -26.9% | -12,879 | 34,968 | 10 Jul 2026 | Direct | ||
| Roger Jeffs | LQDA | Common Stock | Options Exercise | 2.48% | 28,167 | 1,165,675 | 10 Jul 2026 | Direct | ||
| Roger Jeffs | LQDA | Performance Stock Units | Options Exercise | -25.3% | -28,167 | 83,001 | 10 Jul 2026 | Direct | ||
| Jason Adair | LQDA | Common Stock | Options Exercise | 4.77% | 10,251 | 224,989 | 10 Jul 2026 | Direct | ||
| Jason Adair | LQDA | Performance Stock Units | Options Exercise | -29.9% | -6,344 | 14,845 | 10 Jul 2026 | Direct | ||
| Jason Adair | LQDA | Restricted Stock Units | Options Exercise | -33.3% | -3,907 | 7,812 | 10 Jul 2026 | Direct | ||
| Russell Schundler | LQDA | Common Stock | Options Exercise | 1.67% | 10,168 | 620,700 | 10 Jul 2026 | Direct | ||
| Russell Schundler | LQDA | Performance Stock Units | Options Exercise | -31.1% | -10,168 | 22,550 | 10 Jul 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Common Stock | Options Exercise | 4.62% | 8,018 | 181,725 | 10 Jul 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Performance Stock Units | Options Exercise | -27.5% | -8,018 | 21,184 | 10 Jul 2026 | Direct | ||
| Scott Moomaw | LQDA | Common Stock | Options Exercise | 4.05% | 7,466 | 192,024 | 10 Jul 2026 | Direct | ||
| Scott Moomaw | LQDA | Performance Stock Units | Options Exercise | -28.6% | -7,466 | 18,646 | 10 Jul 2026 | Direct | ||
| Dana Boyle | LQDA | Common Stock | Options Exercise | 1.81% | 3,179 | 178,521 | 10 Jul 2026 | Direct | ||
| Dana Boyle | LQDA | Performance Stock Units | Options Exercise | -9.09% | -3,179 | 31,787 | 10 Jul 2026 | Direct | ||
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -6.02% | $4,046,795 | $80.94 | -50,000 | 780,073 | 07 Jul 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -2.92% | $2,004,375 | $80.18 | -25,000 | 830,073 | 06 Jul 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -2.84% | $1,986,695 | $79.47 | -25,000 | 855,073 | 01 Jul 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -10.2% | $7,573,704 | $75.74 | -100,000 | 880,073 | 22 Jun 2026 | See footnote |
| Johnson David Edward | LQDA | Common Stock, $0.001 par value per share ("Common Stock") | Award | 5,882 | 5,882 | 16 Jun 2026 | Direct | |||
| David Edward Johnson | LQDA | Common Stock, $0.001 par value per share ("Common Stock") | Award | 5,882 | 5,882 | 16 Jun 2026 | Direct | |||
| Raman Singh | LQDA | Common Stock | Award | 15.2% | 5,882 | 44,637 | 16 Jun 2026 | Direct | ||
| Dr. Stephen M. Bloch | LQDA | Common Stock | Award | 8.95% | 5,882 | 71,594 | 16 Jun 2026 | Direct | ||
| Damian deGoa | LQDA | Common Stock | Award | 6.8% | 5,882 | 92,353 | 16 Jun 2026 | Direct | ||
| Dr. Joanna Horobin | LQDA | Common Stock | Award | 17.4% | 5,882 | 39,637 | 16 Jun 2026 | Direct | ||
| Arthur S. Kirsch | LQDA | Common Stock | Award | 14.4% | 5,882 | 46,637 | 16 Jun 2026 | Direct | ||
| Katherine Rielly-Gauvin | LQDA | Common Stock | Award | 15.2% | 5,882 | 44,637 | 16 Jun 2026 | Direct | ||
| Paul B. Manning | LQDA | Common Stock | Award | 1.25% | 5,882 | 475,465 | 16 Jun 2026 | Direct | ||
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -7.99% | $6,076,486 | $71.44 | -85,062 | 980,073 | 15 Jun 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -9.44% | $7,936,094 | $71.46 | -111,049 | 1,065,135 | 12 Jun 2026 | See footnote |
| Sarah Krepp | LQDA | Common Stock | Sale | -17% | $1,748,527 | $70.28 | -24,880 | 121,863 | 11 Jun 2026 | Direct |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -17.1% | $17,062,444 | $70.43 | -242,269 | 1,176,184 | 11 Jun 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -9.33% | $9,572,345 | $65.58 | -145,954 | 1,418,453 | 10 Jun 2026 | See footnote |
* marks a reported price that did not pass the local price check.